Increase in number of cases of acute and chronic pancreatitis linked to GLP-1 medicines owenhaskins Jun 26, 2025 2 min read Data from the UKs medicines regulator, the Medicines and Healthcare products Regulatory Agency (MHRA), has revealed that since glucagon-like peptide-1 receptor agonists (GLP-1) were licensed there have been hundreds of cases of acute and chronic pancreatitis among people taking GLP-1 medicines
(2015) Identification of H2S3 and H2S produced by 3-mercaptopyruvate sulfurtransferase in the brain
During this healing period, managing weight becomes more difficult as the digestive system remains compromised
There is a lot of misinformation out there regarding GLP-1s, she said
Our weight loss program in Florida uses GLP-1 medications including Ozempic, Mounjaro, Wegovy, Zepbound, and more to help patients lose weight and reach their goals under the guidance of a licensed provider
The relief from GLP-1 medications isn't always permanent, and it isn't always perfectly steady